Da effekten og sikkerheden af Intrinsa ikke er blevet vurderet i forsøg af længere varighed end 1 år, anbefales det at foretage en vurdering af behandlingen hver 6. måned.
As the efficacy and safety of Intrinsa have not been evaluated in studies of longer duration than 1 year, it is recommended that an appraisal of the treatment is undertaken every 6 months.